Table I. Top discrimination proteins between BRCA1-deficient and -proficient mammary tumors after short term cisplatin treatment.
NA means not applicable.
Description | International protein index | Gene ontology | Human gene names | Significant regulation in sensitive modela | Fold change in sensitive modela | p value in sensitive tumorsa | Significant regulation in resistant modela | Fold change in resistant modela | p value in resistant tumorsa | Top 30 proteinsb | Top 12 proteinsc |
---|---|---|---|---|---|---|---|---|---|---|---|
Fatty-acid synthase | IPI00113223 | Lipid metabolic process | FASN | −1.3 | 0.0697 | ↑ | 1.7 | 0.0173 | x | x | |
Kii-67 protein | IPI00124959 | M phase | MKI67 | ↑ | 1.5 | 0.0118 | ↑ | 7.1 | 0.0062 | x | x |
Carbonic anhydrase 3 | IPI00221890 | Small molecule metabolic process | CA3 | ↓ | −13.9 | 0.0000 | ↑ | 1.6 | 0.0089 | x | x |
Fatty acid-binding protein, adipocyte | IPI00116705 | Lipid metabolic process | FABP4 | ↓ | −2.6 | 0.0099 | ↑ | 1.6 | 0.0066 | x | x |
Chromodomain-helicase-DNA-binding protein 4 | IPI00396802 | Chromosome organization | CHD4 | ↑ | 1.6 | 0.0221 | −1.0 | 0.4882 | x | x | |
Nuclear pore membrane glycoprotein 210 precursor | IPI00342158 | Establishment of protein localization | NUP21 | ↑ | 1.9 | 0.0110 | −2.0 | 0.2815 | x | x | |
Kinesin-like protein KIF11 | IPI00130218 | Mitotic spindle organization | KIF11 | ↑ | 2.6 | 0.0106 | ↑ | 11.1 | 0.0281 | x | x |
EH domain-containing protein-2 homolog | IPI00402968 | Organelle organization | EHD2 | −2.3 | 0.0996 | ↑ | 1.5 | 0.0470 | x | x | |
Glutathione S-transferase Mu 1 | IPI00230212 | Metabolic process | GSTM1 | ↓ | −1.8 | 0.0252 | 1.2 | 0.2058 | x | x | |
Pyruvate carboxylase, full insert sequence | IPI00114710 | Lipid metabolic process | PC | ↓ | −2.5 | 0.0144 | ↑ | 2.8 | 0.0261 | x | x |
Perilipin | IPI00223783 | Lipid metabolic process | PLIN1 | −1.1 | 0.3851 | ↓ | −1.6 | 0.0334 | x | x | |
Condensation protein G isoform 1 | IPI00122202 | M phase | NCAPG | ↑ | 1.9 | 0.0171 | 1.4 | 0.2403 | x | x | |
Major vault protein | IPI00111258 | mRNA transport | MVP | 2.0 | 0.2809 | ↓ | −3.3 | 0.0378 | x | ||
Small nuclear ribonucleoprotein Sm D2 | IPI00119220 | Nucleic acid metabolic process | SNRPD | ↑ | 1.7 | 0.0320 | −1.1 | 0.4066 | x | ||
γ-Synuclein | IPI00271440 | Regulation of neurotransmitter secretion | SNCG | −3.8 | 0.1126 | ↑ | 5.7 | 0.0045 | x | ||
Thymidylate kinase, full insert sequence | IPI00831272 | Deoxyribonucleotide biosynthetic process | DTYMK | ↑ | 2.4 | 0.0189 | −1.3 | 0.2717 | x | ||
Galactokinase 1 | IPI00265025 | Monosaccharide metabolic process | GALK1 | ↑ | 1.6 | 0.0425 | −1.2 | 0.2653 | x | ||
Isoform 1 of nuclear autoantigenic sperm protein | IPI00130959 | Chromosome organization | NASP | ↑ | 2.0 | 0.0242 | 1.4 | 0.2464 | x | ||
Kinesin family member 23 | IPI00407864 | Mitotic spindle organization | KIF23 | ↑ | 7.7 | 0.0030 | 1.7 | 0.3034 | x | ||
Flap structure-specific endonuclease 1, full insert | IPI00410836 | Nucleic acid metabolic process | FEN1 | ↑ | 1.9 | 0.0350 | 2.0 | 0.0937 | x | ||
Tubulin-specific chaperone D | IPI00461857 | Macromolecule metabolic process | TBCD | ↑ | 1.9 | 0.0447 | −1.5 | 0.1893 | x | ||
Actin-binding protein anillin | IPI00172197 | Nuclear division | ANLN | ↑ | 4.7 | 0.0078 | 7.0 | 0.0597 | x | ||
Ribonucleoside-diphosphate reductase M2 subunit | IPI00112645 | Deoxyribonucleotide biosynthetic process | RRM2 | ↑ | 3.0 | 0.0249 | 2.0 | 0.2784 | x | ||
Isoform 1 of Mitochondrial 28 S ribosomal protein S29 | IPI00275050 | Cellular component organization | DAP3 | ↑ | 2.6 | 0.0332 | −1.0 | 0.4984 | x | ||
Isoform 1 of Borealin | IPI00621765 | M phase | CDCA8 | ↑ | 3.5 | 0.0420 | 1.0 | 1.0000 | x | ||
Pre-mRNA-splicing factor ISY1 homolog | IPI00469994 | Nucleic acid metabolic process | ISY1 | ↑ | 3.5 | 0.0431 | −1.7 | 0.3100 | x | ||
39S ribosomal protein L24, mitochondrial precursor | IPI00162769 | Macromolecule biosynthetic process | MRPL2 | ↑ | 5.0 | 0.0435 | 1.0 | 1.0000 | x | ||
Uncharacterized protein C6orf130 homolog | IPI00154005 | Purine nucleoside binding | C6orf1 | ↑ | 100.0 | 0.0106 | 1.0 | 1.0000 | x | ||
Isoform 1 of protein FAM76B | IPI00330763 | NA | FAM76 | ↑ | 100.0 | 0.0108 | 1.0 | 1.0000 | x | ||
Maternal embryonic leucine zipper kinase | IPI00323045 | Cellular macromolecule metabolic process | MELK | ↑ | 100.0 | 0.0108 | 1.0 | 1.0000 | x | ||
Ligase I, DNA, ATP-dependent | IPI00473314 | Nucleic acid metabolic process | LIG1 | ↑ | 2.7 | 0.0097 | 1.5 | 0.1850 | |||
Cation-independent mannose 6-phosphate receptor | IPI00308971 | Positive regulation of apoptosis | IGF2R | ↑ | 1.5 | 0.0497 | ↓ | −1.6 | 0.0351 | ||
Glutathione S-transferase, θ3 | IPI00116236 | Glutathione metabolic process | Gstt3 | ↑ | 2.9 | 0.0358 | 1.0 | 0.4967 | |||
Hsp90 co-chaperone Cdc37 | IPI00117087 | M phase | CDC37 | ↑ | 2.1 | 0.0200 | 1.0 | 0.4925 | |||
Thyroid hormone receptor-associated protein 3 | IPI00556768 | Nucleic acid metabolic process | THRAP | ↑ | 2.5 | 0.0143 | 1.0 | 0.4933 | |||
Isoform E of Fragile × mental retardation syndrome-related protein 1 | IPI00122521 | Regulation of translation | FXR1 | ↑ | 100.0 | 0.0019 | −1.3 | 0.2467 | |||
Isoform 2 of U2-associated protein SR140 | IPI00467507 | RNA processing | U2SUR | ↑ | 2.4 | 0.0401 | 1.2 | 0.3749 | |||
Aggrecan core protein precursor | IPI00119035 | Proteolysis | Acan | 1.0 | 1.0000 | ↓ | −6.1 | 0.0054 | |||
mRNA turnover protein 4 homolog | IPI00132578 | Ribosome biogenesis | MRTO4 | ↑ | 1.7 | 0.0457 | 1.2 | 0.3036 | |||
Isoform 7 of protein quaking | IPI00130483 | mRNA transport | QKI | −1.0 | 0.4981 | ↑ | 9.4 | 0.0004 | |||
Monocarboxylate transporter 4 | IPI00118910 | Monocarboxylic acid transport | SLC16 | ↑ | 6.0 | 0.0272 | −1.0 | 0.4990 | |||
Carbonic anhydrase 2 | IPI00121534 | Metabolic process | CA2 | ↓ | −1.9 | 0.0353 | 1.1 | 0.4305 | |||
Myosin IE | IPI00330649 | Vasculogenesis | MYO1E | 1.3 | 0.2303 | ↓ | −1.7 | 0.0495 | |||
Niban-like protein | IPI00330695 | Negative regulation of apoptotic process | FAM12 | −1.4 | 0.3426 | ↓ | −1.8 | 0.0208 | |||
Vesicle-associated membrane protein-associated protein | IPI00135655 | Nucleotide catabolic process | VAPB | 3.0 | 0.1509 | ↓ | −6.0 | 0.0261 | |||
Isoform 1 of double strand break repair protein MRE11A | IPI00118853 | Nucleic acid metabolic process | MRE11 | ↑ | 100.0 | 0.0106 | −1.7 | 0.3082 | |||
Vesicle-associated membrane protein-associated protein | IPI00125267 | Cellular membrane fusion | VAPA | ↑ | 1.9 | 0.0333 | −1.3 | 0.1713 | |||
Isoform 2 of acetyl-CoA carboxylase 1 | IPI00848443 | Lipid metabolic process | ACACA | 1.5 | 0.2119 | ↓ | −2.7 | 0.0342 | |||
ADP-ribosylation factor interacting protein 1 | IPI00466057 | Establishment of localization in cell | ARFIP1 | ↑ | 100.0 | 0.0057 | −2.0 | 0.1596 | |||
Actin, cytoplasmic type 5 homolog | IPI00221528 | Nucleotide and ATP binding | ACTBL | 1.1 | 0.2369 | ↑ | 2.4 | 0.0200 | |||
Isoform 1 of translation initiation factor eIF-2B subunit | IPI00124879 | Metabolic process | EIF2B4 | ↓ | −100.0 | 0.0116 | 3.0 | 0.1514 | |||
Pno1 RNA-binding protein PNO1 | IPI00131909 | RNA binding | PNO1 | ↓ | −5.0 | 0.0444 | 1.0 | 0.4991 | |||
Isoform Long of Extracellular matrix protein 1 precursor | IPI00122272 | System development | ECM1 | −1.3 | 0.2637 | ↓ | −2.4 | 0.0106 | |||
Itih1 protein | IPI00322867 | Metabolic process | ITIH1 | ↓ | −1.7 | 0.0130 | 1.1 | 0.2890 | |||
Ubiquitin-activating enzyme E1-like protein 2 | IPI00226815 | Proteolysis involved in cellular protein catabolic process | UBA6 | 2.8 | 0.0556 | ↓ | −2.1 | 0.0358 | |||
Golgi resident protein GCP60 | IPI00129907 | Metabolic process | ACBD3 | ↓ | −2.9 | 0.0442 | 7.0 | 0.0597 |
a The fold change and one-sided p value were calculated between protein levels in control and treated tumors.
b Top proteins with an average eight spectral count difference between treated tumors are given.
c Proteins with significant (p > 0.05, two-sided) difference between treated tumors are shown.